Resound Nexia vs Vivtone Xpure Hearing Aid

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earned a SoundScore of 4.0/5 and an A grade, ranking #28 of 39 prescription hearing aids tested. The Nexia demonstrates clear strengths in specific areas. Feedback handling is excellent at 5.0/5, scoring 0.28 points above the category average—users can expect stable performance without whistling during typical daily activities. Own-voice comfort also stands out at 3.6/5, a solid score that sits 0.90 points above average, suggesting wearers may find their own voice sounds more natural compared to many competitors. However, speech performance presents a more mixed picture. Speech in quiet measures 3.2/5—solid in absolute terms but 0.19 points below the category average. More notably, speech in noise scores just 1.0/5, falling 1.11 points below average. This represents a significant limitation for users who frequently encounter challenging listening environments like restaurants or group conversations. Music streaming scores 2.8/5, essentially matching the category average. At this price point, several alternatives deliver stronger overall performance. The Phonak Sphere Infinio, Oticon Intent, and Oticon Real all score notably higher while occupying the same premium tier. Budget-conscious buyers might also consider options like the Jabra Enhance Select 500 at a lower price point with competitive sound quality. The Nexia may be best suited for users who prioritize feedback stability and own-voice comfort over speech-in-noise performance.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.